Evidence map›Paper›PMID 25274991›Full record

ArticleJournal of clinical microbiology2014

Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.

Aurélie Renvoisé, Christine Bernard, Nicolas Veziris, Eve Galati, Vincent Jarlier, Jérôme Robert

Abstract readComparative StudyLetter
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Differences in Drug-Susceptibility Patterns betweenAntibiotics (Basel, Switzerland) · 2022
    Article
  3. Variability ofAntibiotics (Basel, Switzerland) · 2022
    Review
  4. High diversity of clinicalFrontiers in public health · 2022
    Article
  5. Article
  6. Rational Choice of Antibiotics and Media forFrontiers in microbiology · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aurélie RenvoiséAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Univ Paris 06, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France.
Christine BernardAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Univ Paris 06, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France.
Nicolas VezirisAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Univ Paris 06, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France.
Eve GalatiAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France.
Vincent JarlierAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Univ Paris 06, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France.
Jérôme RobertAP-HP, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Univ Paris 06, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Center for Immunology and Microbial Infections, Team 13, Paris, France jerome.robert0@upmc.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmikacinAntitubercular AgentsClarithromycinHumansMicrobial Sensitivity TestsMycobacterium aviumMycobacterium avium ComplexAmikacinAntitubercular AgentsClarithromycin

Identifiers

PMID25274991
PMCPMC4313332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.